Your browser is no longer supported. Please, upgrade your browser.
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E30.10 EPS (ttm)5.40 Insider Own0.08% Shs Outstand2.63B Perf Week-1.85%
Market Cap435.27B Forward P/E15.87 EPS next Y10.25 Insider Trans-3.16% Shs Float2.63B Perf Month-2.04%
Income14.41B PEG5.67 EPS next Q2.32 Inst Own69.80% Short Float0.58% Perf Quarter11.09%
Sales82.58B P/S5.27 EPS this Y0.50% Inst Trans-0.12% Short Ratio1.89 Perf Half Y6.86%
Book/sh24.49 P/B6.64 EPS next Y7.90% ROA9.50% Target Price185.44 Perf Year12.40%
Cash/sh11.50 P/C14.14 EPS next 5Y5.31% ROE24.50% 52W Range109.16 - 173.65 Perf YTD3.31%
Dividend4.04 P/FCF59.79 EPS past 5Y-0.20% ROI17.30% 52W High-6.30% Beta0.71
Dividend %2.48% Quick Ratio1.20 Sales past 5Y2.00% Gross Margin65.70% 52W Low49.06% ATR2.88
Employees132200 Current Ratio1.50 Sales Q/Q1.70% Oper. Margin19.80% RSI (14)49.63 Volatility1.66% 1.61%
OptionableYes Debt/Eq0.59 EPS Q/Q102.80% Profit Margin18.40% Rel Volume1.03 Prev Close162.59
ShortableYes LT Debt/Eq0.51 EarningsJan 26 BMO Payout66.90% Avg Volume8.09M Price162.71
Recom1.90 SMA20-0.97% SMA501.62% SMA2008.45% Volume3,127,098 Change0.07%
Apr-28-20Downgrade UBS Buy → Neutral $163 → $160
Apr-22-20Upgrade BofA/Merrill Neutral → Buy $150 → $175
Mar-05-20Initiated Citigroup Buy $163
Dec-19-19Upgrade Barclays Equal Weight → Overweight $173
Dec-17-19Upgrade Morgan Stanley Equal-Weight → Overweight $145 → $170
Nov-20-19Initiated Cantor Fitzgerald Overweight $160
Oct-16-19Upgrade Atlantic Equities Underweight → Neutral
Oct-11-19Upgrade Bernstein Mkt Perform → Outperform $155
Jul-12-19Resumed Credit Suisse Outperform $156
May-28-19Initiated Goldman Buy
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Feb-25-21 10:19AM  
10:13AM  
09:00AM  
07:00AM  
06:06AM  
03:49AM  
02:04AM  
Feb-24-21 10:33PM  
07:28PM  
07:00PM  
04:46PM  
04:44PM  
04:42PM  
04:38PM  
04:00PM  
01:15PM  
12:15PM  
12:13PM  
10:46AM  
10:14AM  
09:55AM  
09:51AM  
09:31AM  
09:24AM  
08:14AM  
08:09AM  
08:09AM  
08:03AM  
07:15AM  
06:17AM  
04:08AM  
03:52AM  
03:18AM  
Feb-23-21 07:00PM  
05:18PM  
03:54PM  
02:05PM  
10:55AM  
10:50AM  
09:43AM  
08:56AM  
06:40AM  
06:11AM  
02:00AM  
Feb-22-21 10:41PM  
10:30PM  
06:13PM  
05:23PM  
04:55PM  
03:58PM  
08:01AM  
07:46AM  
07:14AM  
06:07AM  
Feb-21-21 04:57PM  
06:20AM  
05:45AM  
Feb-20-21 06:45AM  
06:01AM  
Feb-19-21 01:00PM  
12:48PM  
12:43PM  
12:43PM  
10:54AM  
10:45AM  
07:48AM  
07:43AM  
07:30AM  
Feb-18-21 12:36PM  
11:08AM  
10:18AM  
09:52AM  
09:25AM  
08:23AM  
07:05AM  
Feb-17-21 09:58PM  
06:36PM  
02:14PM  
12:33PM  
11:40AM  
11:38AM  
11:15AM  
06:11AM  
04:12AM  
Feb-16-21 11:38PM  
02:02PM  
10:00AM  
09:32AM  
07:00AM  
04:15AM  
Feb-15-21 07:00PM  
Feb-14-21 06:14AM  
Feb-13-21 01:02PM  
09:15AM  
07:03AM  
06:10AM  
Feb-12-21 05:21PM  
02:33PM  
11:56AM  
11:45AM  
Johnson & Johnson researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular diseases; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stoffels PaulusVice Chair, Exec CommitteeFeb 12Option Exercise0.0035,0620289,864Feb 17 07:09 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 12Option Exercise0.0013,6060121,191Feb 17 07:09 PM
Ullmann Michael HExec VP, General CounselFeb 12Option Exercise0.0014,4440157,728Feb 17 07:09 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 12Option Exercise0.0010,362068,837Feb 17 07:09 PM
Wolk Joseph JExec VP, CFOFeb 12Option Exercise0.005,086024,513Feb 17 07:09 PM
Decker Robert JController, CAOFeb 12Option Exercise0.001,310014,701Feb 17 07:09 PM
Gorsky AlexChairman, CEOFeb 12Option Exercise0.0075,1050507,925Feb 17 07:09 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 12Option Exercise0.007,145042,960Feb 17 07:09 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 12Option Exercise0.0033,0210209,490Feb 17 07:09 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 12Option Exercise0.0012,8730113,039Feb 17 07:09 PM
Sneed Michael EEVP, Global Corp Aff & CCOFeb 12Option Exercise0.009,211065,290Feb 17 07:09 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 12Option Exercise0.0013,136034,834Feb 17 07:09 PM
Sneed Michael EEVP, Global Corp Aff & COODec 09Option Exercise62.2054,6623,399,976110,741Dec 10 06:19 PM
Sneed Michael EEVP, Global Corp Aff & COODec 09Sale152.9354,6628,359,46056,079Dec 10 06:19 PM
Wengel Kathryn EEVP, Chief GSC OfficerSep 02Option Exercise63.7516,1151,027,32374,535Sep 04 02:58 PM
Wengel Kathryn EEVP, Chief GSC OfficerSep 02Sale153.5216,1152,473,93858,420Sep 04 02:58 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesJul 28Sale147.4729,0004,276,63021,682Jul 28 06:43 PM
JOHNSON & JOHNSON10% OwnerJun 30Buy17.00725,00012,325,0003,670,516Jul 02 04:58 PM
PEREZ WILLIAM DDirectorMar 13Buy127.6950063,84316,030Mar 17 04:24 PM